Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor

H.V. Kusters-Vandevelde, A.E. Willemsen, PJ.T. Groenen, B. Kusters, M. Lammens, P. Wesseling, M. Djafarihamedani, J. Rijntjes, H. Delye, M.A. Willemsen, C.M. van Herpen, W.A. Blokx

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Article number41
JournalActa Neuropathologica Communinications
Volume2
DOIs
Publication statusPublished - 2014

Cite this